MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer

Cellular Physiology and Biochemistry

Volumn 31, Issue 1, 2013, Pages 56-65

  Zhang, Huijun ^a   Zheng, Hui ^a   Zhao, Mingchuan ^a   Lv, Zhongwei ^a   Zhang, Xiaoping ^a   Qin, Xiong ^a   Wang, Heyong ^a   Wang, Shaohua ^b   Su, Jinmei ^a   Lv, Xin ^a   Liu, Hongcheng ^a   Du, Weijia ^a   Zhou, Wenyong ^a   Chen, Xiaofeng ^a   Fei, Ke ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

EZH2; miR 138; NSCLC

Indexed keywords

MICRORNA; MICRORNA 138; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER REGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; APOPTOSIS; CANCER INHIBITION; CANCER PATIENT; CELL CYCLE; CELL GROWTH; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG PARENCHYMA; NON SMALL CELL LUNG CANCER; REVERSE TRANSCRIPTION; RNA ISOLATION; TUMOR INVASION; WESTERN BLOTTING;

EID: 84872816163     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343349     Document Type: Article

References (28)

1. Liu XH, Lu KH, Wang KM, Sun M, Yang JS, Zhang EB, Yin DD, Liu ZL, Zhou J, Liu ZJ, De W, Wang ZX: MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer 2012;12:348-349.
2. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics. CA Cancer J Clin 2010;60:277-300.
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I: Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784-796.
4. Ambros V: The functions of animal microRNAs. Nature 2004;431:350-355.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
6. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-531.
7. Hwang HW, Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2007;96:R40-R44.
8. Maatouk D, Harfe B: MicroRNAs in development. Sci World J 2006;6:1828-1840.
9. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB, Nana-Sinkam SP: MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008:373:607-612.
10. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH: MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010;411:846-852.
11. Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H: Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer Mol Cancer Res 2010;8:1207-1216.
12. Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A, Hu J: miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res 2010;29:151-155.
13. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J: MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009;4:e6677.
14. Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ: MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2. J Thorac Oncol 2011;6:671-678.
15. Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J: A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis. Clin Cancer Res 2011;17:6802-6811.
16. Wang W Zhao LJ, Tan YX, Ren H, Qi ZT: MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 2012;33:1113-1120.
17. Liu X, Jiang L, WangA, Yu J, Shi F, Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009;286:217-222.
18. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
19. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature ofhuman solid tumors defines cancer gene targets. Proc Natl Acad SciUSA 2006;103:2257-2261.
20. Liu X, Chen Z, Yu J, Xia J, Zhou X: MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009;2009:837514.
21. Jiang L, Dai Y, Liu X, Wang C, Wang A, Chen Z, Heidbreder CE, Kolokythas A, Zhou X: Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNA12) as a microRNA-138 target in tongue squamous cell carcinoma. Hum Genet 2011;129:189-197.
22. Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K, Wu M, Liang Y, Liu P, Tang J, Lu WH, Feng QS, Chen LZ, Qian CN, Bei JX, Kang T, Zeng YX: MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle 2012;11:2495-2506.
23. Chen Y, Lin MC, Wang H, Chan CY, Jiang L, Ngai SM, Yu J, He ML, Shaw PC, Yew DT, Sung JJ, Kung HF: Proteomic analysis of EZH2 downs tream target proteins in hepatocellular carcinoma. Proteomics 2007;7:3097-3104.
24. Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, Li XP: MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2. Cancer Res 2011;71:225-233.
25. Bryant RJ, Cross NA, Eaton CL, Hamdy FC, Cunliffe VT: EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate 2007;67:547-556.
26. ZhangYB, Niu HT, Chang JW, Dong GL, Ma XB: EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines. Eur J Cancer Care (Engl) 2011:20:106-112.
27. Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H: Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci 2006;97:484-491.
28. Kisliouk T, Yosefi S, Meiri N: MiR-138 inhibits EZH2 methyltransferase expression and methylation of histone H3 at lysine 27, and affects thermotolerance acquisition. Eur J Neurosci 2011;33:224-235.